摘要
原文 | 英語 |
---|---|
文章編號 | 143 |
期刊 | Journal of Ovarian Research |
卷 | 13 |
發行號 | 1 |
DOIs | |
出版狀態 | 已發佈 - 12月 2020 |
ASJC Scopus subject areas
- 腫瘤科
- 婦產科
指紋
深入研究「Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report」主題。共同形成了獨特的指紋。資料集
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Chang, L. (Contributor), Chen, L. (Contributor), Lai, H. (Contributor), Sung, P. (Contributor), Chou, Y. (Contributor), Liew, P. (Contributor), Lin, Y. (Contributor), Huang, R. (Contributor) & Wen, K. (Contributor), figshare Academic Research System, 1月 1 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://doi.org/10.6084%2Fm9.figshare.13352142.v1
資料集: Dataset
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Wen, K. (Contributor), Chen, L. (Contributor), Chou, Y. (Contributor), Chang, L. (Contributor), Huang, R. (Contributor), Lin, Y. (Contributor), Lai, H. (Contributor), Sung, P. (Contributor) & Liew, P. (Contributor), figshare Academic Research System, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://doi.org/10.6084%2Fm9.figshare.c.5234313.v1
資料集: Dataset